IDXX vs VERO · P/E 40, rev $2.36B vs rev $64.8M
IDEXX Laboratories Inc (IDXX) versus Venus Concept Inc (VERO) — a side-by-side from cached financials, not a winner call.
IDEXX Laboratories Inc (IDXX) is a diagnostics & research company listed on NASDAQ.
Venus Concept Inc (VERO) is a medical devices company listed on NASDAQ.
Latest reported IDXX revenue for 2026-06-30 was $2.36B. Net income was $616.9M. IDXX currently screens at market cap $43.08B and trailing P/E 40.2.
Latest reported VERO revenue for 2024-12-31 was $64.8M. Net income was -$47.0M. Revenue was down 15.1% from 2023-12-31 to 2024-12-31. VERO currently screens at market cap $578.2K.
IDXX currently screens at market cap $43.08B and trailing P/E 40.2. VERO currently screens at market cap $578.2K.
Not investment advice. Open the IDXX and VERO stock pages for the full models.
Not investment advice.